ArticleJournal of proteome research2026
Liver and Kidney Tissues Under Opioid Exposure: Rewriting and Old Story Through Proteomics and MALDI-MSI.
Article in Journal of proteome research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Selective Dopamine Transporter Inhibition with CE-123 Promotes Fear Extinction and Alters the Basolateral Amygdala Proteome Following Fear Extinction in Adolescent Male Rats.International journal of molecular sciences · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
A proteomic analysis of rat liver and kidney was performed following exposure to morphine (10 mg/kg, 10 days) versus untreated controls. Our data revealed alterations in numerous protein expression. Differences were observed in pro- and antiapoptotic signaling, oxidative stress response, transport mechanisms, nucleic acid metabolism, and regulators of alternative splicing, among others. Liver tissue exhibited primarily adaptive changes, including upregulation of metabolic enzymes and subtle markers of oxidative stress. In contrast, the kidneys displayed a broader spectrum of proteomic alterations, affecting a wider array of functional pathways, suggesting that this organ may be more susceptible to morphine-induced toxicity or that of its metabolites. We employed also MALDI-MSI to examine lipidomic alterations: while no significant changes were detected in liver tissue, important lipidomic alterations were observed in the kidneys, further supporting their increased vulnerability to morphine exposure. Our results should be regarded as preliminary; however, they highlight a promising direction for identifying early stage protein markers of toxicity using proteomic approaches. Monitoring such markers could prove valuable in multidrug therapies, particularly for patients with a history of hepatic or renal impairment, contributing to the development of safer therapeutic strategies. Data are available via ProteomeXchange under the identifiers: PXD067999 (DDA) and PXD068084 (DIA).
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.